The percentages of circulating iNKT cells were also lower in patients with colorectal cancer ( n = 33), lung cancer ( n = 8) and RCC ( n = 10) than healthy controls but the difference did not reach statistical significance.
← all excerpts
Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
1
—
—